Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

[1]  Wenjun Ma,et al.  Transmission dynamics of 2019 novel coronavirus (2019-nCoV) , 2020, bioRxiv.

[2]  R. Couch,et al.  Development and application of an enzyme immunoassay for coronavirus OC43 antibody in acute respiratory illness , 1994, Journal of clinical microbiology.

[3]  O. Diekmann,et al.  Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation , 2000 .

[4]  C. Fraser,et al.  Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions , 2003, Science.

[5]  B J Cowling,et al.  Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[6]  R. Stein,et al.  Human coronavirus alone or in co-infection with rhinovirus C is a risk factor for severe respiratory disease and admission to the pediatric intensive care unit: A one-year study in Southeast Brazil , 2019, PloS one.

[7]  J. Hyman,et al.  Model Parameters and Outbreak Control for SARS , 2004, Emerging infectious diseases.

[8]  V. Nomellini,et al.  Murray and Nadel’s Textbook of Respiratory Medicine , 2012 .

[9]  M. V. Van Kerkhove,et al.  Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018 , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  C. Fraser,et al.  Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups , 2005, Epidemiology and Infection.

[11]  K. Yuen,et al.  Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou , 2018, PloS one.

[12]  K. Yuen,et al.  Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus , 2009, Journal of Clinical Virology.

[13]  Kow-Tong Chen,et al.  SARS in Healthcare Facilities, Toronto and Taiwan , 2004, Emerging infectious diseases.

[14]  E. Jung,et al.  Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study , 2015, BMC Medicine.

[15]  Neil M. Ferguson,et al.  The effect of public health measures on the 1918 influenza pandemic in U.S. cities , 2007, Proceedings of the National Academy of Sciences.

[16]  E. Walsh,et al.  Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations , 2013, The Journal of infectious diseases.

[17]  J. Robins,et al.  Transmission Dynamics and Control of Severe Acute Respiratory Syndrome , 2003, Science.

[18]  Christl A. Donnelly,et al.  Unraveling the drivers of MERS-CoV transmission , 2016, Proceedings of the National Academy of Sciences.

[19]  A. Kucharski,et al.  The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[20]  Simon Cauchemez,et al.  Edinburgh Research Explorer Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility , 2022 .

[21]  Zhian N. Kamvar,et al.  Outbreak analytics: a developing data science for informing the response to emerging pathogens , 2019, Philosophical Transactions of the Royal Society B.

[22]  L. Yang,et al.  Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak , 2020, bioRxiv.

[23]  M. Drebot,et al.  An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus. , 2006, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[24]  P. E. Kopp,et al.  Superspreading and the effect of individual variation on disease emergence , 2005, Nature.

[25]  R. Brookmeyer,et al.  Incubation periods of acute respiratory viral infections: a systematic review , 2009, The Lancet Infectious Diseases.

[26]  Benjamin J Cowling,et al.  A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan , 2010, BMC infectious diseases.

[27]  John S Brownstein,et al.  Real-time Epidemic Forecasting: Challenges and Opportunities. , 2019, Health security.

[28]  J. R. Mason,et al.  Murray and Nadel's Textbook of Respiratory Medicine , 2015 .

[29]  Qun Li,et al.  An Outbreak of NCIP (2019-nCoV) Infection in China — Wuhan, Hubei Province, 2019−2020 , 2020 .

[30]  Julien Riou,et al.  Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk , 2013, The Lancet.

[31]  Christophe Fraser,et al.  The Epidemiology of Severe Acute Respiratory Syndrome in the 2003 Hong Kong Epidemic: An Analysis of All 1755 Patients , 2004, Annals of Internal Medicine.

[32]  Marc Lipsitch,et al.  Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1. , 2011, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[33]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[34]  P. Simmonds,et al.  Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method , 2010 .

[35]  L. S. Hung.  The SARS Epidemic in Hong Kong: What Lessons have we Learned? , 2003, Journal of the Royal Society of Medicine.

[36]  Charles Poynton,et al.  Frequently Asked Questions about Color , 1997 .

[37]  Benjamin J. Cowling,et al.  Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia , 2016, Scientific Reports.

[38]  Jieun Park,et al.  MERS transmission and risk factors: a systematic review , 2018, BMC Public Health.

[39]  L. Fang,et al.  Case fatality of SARS in mainland China and associated risk factors , 2009, Tropical medicine & international health : TM & IH.

[40]  Nam Joong Kim,et al.  Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea , 2018, The Korean journal of internal medicine.

[41]  Gheyath K Nasrallah,et al.  Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar , 2019, Journal of immunology research.

[42]  D. Cummings,et al.  Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions , 2020, medRxiv.

[43]  P. Lemey,et al.  Complete Genomic Sequence of Human Coronavirus OC43: Molecular Clock Analysis Suggests a Relatively Recent Zoonotic Coronavirus Transmission Event , 2005, Journal of Virology.

[44]  Lin Wang,et al.  Characterizing the dynamics underlying global spread of epidemics , 2018, Nature Communications.